The US Food and Drug Administration allows Abbott Laboratories Ltd. to restart production at its Sturgis, MI, infant formula plant a consent decree on steps necessary while also launching temporary enforcement discretion to encourage production from other firms to eliminate shortage.
A consent agreement Abbott agreed to with the FDA details maintenance of the plant operated by its Abbott Nutrition business is subject to court approval, the firm announced on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?